Back
PTC Therapeutics Stock Price Chart

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
43
PTCT
PTC Therapeutics
Last Price:
$50.18
Seasonality Move:
15.23%
7 Day Trial
ALL ACCESS PASS
$
7

How to hack a $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
The current trend is moderately bullish and PTCT is experiencing slight selling pressure.
PTC Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.02 | Sell |
20-day SMA: | 49.92 | Buy |
50-day SMA: | 47.59 | Buy |
200-day SMA: | 45.19 | Buy |
8-day EMA: | 50.77 | Sell |
20-day EMA: | 49.95 | Buy |
50-day EMA: | 48.86 | Buy |
200-day EMA: | 45.17 | Buy |
PTC Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 53.33 | Buy |
Chaikin Money Flow: | -973132 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (46.92 - 51.48) | Buy |
Bollinger Bands (100): | (45.08 - 53.22) | Buy |
PTC Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for PTC Therapeutics Stock
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 50.20 while PTCT 8-day simple moving average is 51.02, which is a Sell signal.
-
The stock price of PTCT is 50.20 while PTC Therapeutics 20-day SMA is 49.92, which makes it a Buy.
-
PTC Therapeutics 50-day simple moving average is 47.59 while PTCT share price is 50.20, making it a Buy technically.
-
PTCT stock price is 50.20 and PTC Therapeutics 200-day simple moving average is 45.19, creating a Buy signal.
PTCT Technical Analysis vs Fundamental Analysis
Sell
43
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy or a Sell?
-
PTC Therapeutics stock is rated a SellThe current PTC Therapeutics [PTCT] share price is $50.20. The Score for PTCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
PTC Therapeutics Stock Info
Market Cap:
4B
Price in USD:
50.20
Share Volume:
3.4M
PTC Therapeutics 52-Week Range
52-Week High:
58.38
52-Week Low:
28.72
Sell
43
PTC Therapeutics (PTCT)
is a Sell
PTC Therapeutics Share Price Forecast
-
What is the PTC Therapeutics stock price today?The PTC Therapeutics stock price is 50.20 USD today.
-
Will PTCT stock go up or go down?PTC Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is PTC Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, PTC Therapeutics is overvalued.
Is PTC Therapeutics Stock a Buy?
-
PTC Therapeutics share price is 50.20 while PTCT 8-day exponential moving average is 50.77, which is a Sell signal.
-
The stock price of PTCT is 50.20 while PTC Therapeutics 20-day EMA is 49.95, which makes it a Buy.
-
PTC Therapeutics 50-day exponential moving average is 48.86 while PTCT share price is 50.20, making it a Buy technically.
-
PTCT stock price is 50.20 and PTC Therapeutics 200-day simple moving average is 45.17, creating a Buy signal.
Fundamental Analysis of PTC Therapeutics
Is PTC Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.73 per share, an increase this year of $11.47 per share, and a decrease next year of $7.92 per share.
Technical Analysis of PTC Therapeutics
Should I short PTC Therapeutics stock?
-
PTCT Moving Average Covergence Divergence (MACD) indicator is 1.01, suggesting PTC Therapeutics is a Buy
-
PTC Therapeutics Relative Strength Index (RSI) is 53.33, which suggest PTC Therapeutics is overbought
-
The Bollinger Bands (25) for PTC Therapeutics is (46.92 - 51.48), which suggest PTC Therapeutics is a Buy
-
The Bollinger Bands (100) for PTC Therapeutics is (45.08 - 53.22), which suggest PTC Therapeutics is a Buy
* PTC Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.